On April 4, 2025, the Board of Directors (the “Board”) of GoPro, Inc. (the “Company”), on the recommendation of the Company’s Nominating and Governance Committee, appointed Miguel A. Lopez Ben (“Mr. Lopez”) to the Board, effective April 4, 2025.
Role change
(interim)
Donald McClymont
Principal Financial Officer and Principal Accounting Officer
Following Mr. Bal’s departure, the Company’s Chief Executive Officer, Donald McClymont, will assume the duties of principal financial officer and principal accounting officer while the Company conducts a search for a new Chief Financial Officer.
Departed
(interim)
Kanwardev Raja Singh Bal
Chief Financial Officer, Executive Vice President and Chief Accounting Officer
On April 4, 2025, Kanwardev Raja Singh Bal notified indie Semiconductor, Inc. (the “Company”) of his resignation as Chief Financial Officer, Executive Vice President and Chief Accounting Officer of the Company.
On April 4, 2025, the Board appointed Julie Carrillo, the Company’s Corporate Controller, to act as the Principal Accounting Officer of the Company on an interim basis.
Departed
Steven R. Burns
Executive Vice President and Chief Administrative Officer
On April 8, 2025, Steven R. Burns, Executive Vice President and Chief Administrative Officer, notified the Company of his intention to retire from the Company, including its Board of Directors, effective on or about April 30, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
On April 3, 2025, the Board of Directors (the “ Board ”) of the Company determined by unanimous written consent to appoint Ms. Dai as the Company’s permanent Chief Financial Officer (“ CFO ”), effective April 3, 2025.
Fred W. Wagenhals delivered notice to the Board of Directors of the Company (the “ Board ”) of his resignation from his position as the Executive Chairman of the Company and as Chairman of the Board, effective immediately.
On April 3, 2025, the Board appointed Jennifer Sy, age 40, as the Company’s Chief Accounting Officer and principal financial officer, effective as of April 4, 2025.
Appointed
(interim)
Jost Fischer
Interim President, Chief Executive Officer and principal executive officer
On April 3, 2025, the Board formally appointed Mr. Fischer to serve as Interim President, Chief Executive Officer and principal executive officer of the Company, effective as of April 4, 2025.
the Board of Directors of Union Bank, a wholly owned subsidiary of Union Bankshares, Inc. (the "Company") appointed Company Vice President, Treasurer and Chief Financial Officer, Karyn J. Hale, age 55, to the newly created position of Chief Operating Officer of Union Bank.
On April 6, 2025, Edward M. Christie, III, President, Chief Executive Officer and director of Spirit Aviation Holdings, Inc. (the “Company”), stepped down from his role with the Company and the Board of Directors (the “Board”).
On April 4, 2025, the Board of Directors (the “ Board ”) of Amarin Corporation plc (the “ Company ”) appointed Michael Torok, 46, to the Board to a term commencing on such date.
Timothy M. Oxley, Chief Financial Officer (“CFO”) of MasterCraft Boat Holdings, Inc. (the “Company”) announced his resignation as CFO, effective June 30, 2025
appoint John T. Treace to serve as Chairman of the Board, effective upon the expiration of James T. Treace’s current term at the Company’s 2025 Annual Meeting.
Effective as of April 7, 2025, the board of directors (the “Board”) of MBX Biosciences, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “NCG Committee”), appointed Steven L. Hoerter as a director of the Company.
Departed
Alan Pickerill
Director
Leafly Holdings, Inc. /DE
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
Alan Pickerill resigned from the Board of Directors of the Company.
On April 7, 2025, the Board of Directors (the "Board") of Barrett Business Services, Inc. (the "Company") appointed Mark S. Finn, effective April 7, 2025, to serve until the Company's 2025 annual meeting of stockholders, at which time he is expected to stand for re-election.
On April 2, 2025, Peter A. Scott informed Healthpeak Properties, Inc. (the “Company”) of his resignation from his position as Chief Financial Officer of the Company.
On April 7, 2025, NRG Energy, Inc. (the “Company”) issued a press release announcing that Rasesh Patel, Executive Vice President, NRG Consumer, has notified the Company of his retirement from the Company, effective May 19, 2025.
On April 6, 2025, the Board of Directors (the “Board”) of Match Group, Inc. (the “Company”) adopted a resolution appointing Darrell Cavens to the Board
On April 7, 2025, Sarbani Chaudhuri was appointed by Rocket Pharmaceuticals, Inc. (the “Company”) as the Company’s Chief Commercial & Medical Affairs Officer.
On April 3, 2025, Kenneth Miller resigned his employment and position as Chief Commercial Officer of KORU Medical Systems, Inc. (the “Company”), effective immediately, to pursue a Chief Executive Officer role at an organization that does not compete with the Company.
Departed
Michael Gibbs
Senior Vice President, General Counsel and Corporate Secretary
T2 Biosystems, Inc.
Effective
2025-03-18
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On March 18, 2025, Michael Gibbs notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Senior Vice President, General Counsel and Corporate Secretary.
Departed
Laura Adams
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
John Sperzel
Chief Executive Officer and President
T2 Biosystems, Inc.
Effective
2025-03-31
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Chief Executive Officer and President.
Departed
John W. Cumming
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
Robin Toft
Director
T2 Biosystems, Inc.
Effective
2025-03-31
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Departed
Seymour Liebman
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
David Elsbree
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
John Sprague
Chief Financial Officer and Corporate Treasurer
T2 Biosystems, Inc.
Effective
2025-04-03
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John Sprague notified the Company of his resignation from his position as the Company’s Chief Financial Officer and Corporate Treasurer.
Departed
John Sperzel
Director
T2 Biosystems, Inc.
Effective
2025-03-31
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Appointed
Craig R. Jalbert
Class I Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, the Board appointed Craig R. Jalbert, age 63, as a Class I director and the Company’s Chief Executive Officer, President, Corporate Treasurer, and Corporate Secretary, effective as of 11:30 a.m. on April 3, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.